About adivo
adivo is a company based in Planegg (Germany) founded in 2018 by Markus Waldhuber and Kathrin Ladetzki, and was acquired by Zoetis in September 2023. Species-specific antibodies for pets are developed via a specialized platform. adivo offers products and services including Medicines and Vaccines and Diagnostics. Its legal entity is Zoetis Services LLC.
Company details
Adivo was founded in 2018 in Planegg, Germany, within the veterinary biotechnology sector. Technology platforms are developed by the company to create species-specific antibodies tailored for pets. These antibodies are selected from a library of options to ensure optimal fit for animal health applications. Operations focus on advancing antibody development processes for the pet care industry, with co-founders Markus Waldhuber and Kathrin Ladetzki leading efforts.
Products & Services of adivo
adivo offers a comprehensive portfolio of products and services, including Medicines and Vaccines and Diagnostics.
These are developed to predict, prevent, detect, and treat diseases in animals, supporting healthier lives for pets and livestock.
Tools are provided for detecting animal illnesses, which aids in effective health management across various species.
Apps and channels of adivo
its YouTube channel Zoetis has 13.7K subscribers and 30 videos.
Videos from adivo
The most watched videos on adivo's YouTube channel, Zoetis (13.7K subscribers). Click a video to play it here.
More on Zoetis.
Funding Insights of adivo
- Total Rounds 3
- Last Round Grant — $2.45M
- Investors Count 4
All 3 funding rounds of adivo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2022 | $2.45M | Grant | – | – | |
| Apr 2020 | $54,286 | Grant | – | – | |
| Aug 2018 | Seed | – | OCCIDENT – The Science Investor., MorphoSys | – |
5 investors in total: 5 institutional.
Investors in adivo
adivo has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Zoetis, MorphoSys and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Venture capital investments are provided to deep-tech startups. | occident.group | Munich, Germany | ||
Early-stage investments are made in high-tech startups by HTGF. | htgf.de | Bonn, Germany | ||
Therapeutic antibodies for cancer and other diseases are developed. | 1992 | morphosys.com | Planegg, Germany | |
Animal medicines, vaccines, and diagnostics are manufactured and supplied. | 2012 | zoetis.com | Brussels, Belgium |
Investor details for adivo
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of adivo
1040 people are tracked at adivo (319 in leadership, 13 in board & advisors, 708 in team).
| Name | Role | Group |
|---|---|---|
Markus Waldhuber | Co-Founder | Leadership |
Kathrin Ladetzki | Co-Founder & MD | Leadership |
James Henegan | Director For Salesforce Effectiveness, Leadership Development, And Sales Tools | Leadership |
John Drinkell | Director - Business Operations Effectiveness | Leadership |
Shelly Lettman | Communications Director | Leadership |
Michael Stegemann | Executive Director | Leadership |
Marcia Brito | Head Of Transformation | Leadership |
Dori Herczegh | Director, Sr. HRBP Canada & Latam | Leadership |
Alexis Martin | Human Resources Business Partner, Enabling Functions | Leadership |
Stacey F. | Associate Director | Leadership |
Kishore Prayaga | Senior Director | Leadership |
Betty Mason | Head Of Program Management, GMS Biologics Platform | Leadership |
Alexandra Hadfield | Associate Director, Partner Communications & Digital Lead | Leadership |
Tommy Brooks | Director, Head Of Sales | Leadership |
Julian Aymans | Vice President Global External Operations | Leadership |
Darren Remsburg | Associate Director, Veterinary Medical Information & Product Support | Leadership |
Chatterjee Jaydip | Director Supply Chain & Logistics | Leadership |
Todd Odonnell | Vice President Global Transformation | Leadership |
Doug Jenkins | Head Of U.s. Pricing, Contracting, And Customer Operations | Leadership |
Tomasz Dziechciarz | Senior Director, Global Trade Compliance | Leadership |
1020 more people are available in the full profile.
Complete people profiles for adivo
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of adivo
4 dated milestones of adivo across 5 years, from founding to its latest funding, stage changes and deals.
- Founded adivo is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $2.4M.
- Exit Acquired by Zoetis.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about adivo
adivo was founded in 2018.
adivo is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.
Adivo was founded in 2018 in Planegg, Germany, within the veterinary biotechnology sector. Technology platforms are developed by the company to create species-specific antibodies tailored for pets. These antibodies are selected from a library of options to ensure optimal fit for animal health applications. Operations focus on advancing antibody development processes for the pet care industry, with co-founders Markus Waldhuber and Kathrin Ladetzki leading efforts.
adivo offers Medicines and Vaccines and Diagnostics.
adivo has 5 investors. Key investors include Zoetis, MorphoSys, EIC Fund, OCCIDENT, and High-Tech Gründerfonds.
adivo operates through Zoetis Services Llc.
Yes. adivo was acquired by Zoetis in September 2023.